With experimental validation of the RPLARs’ roles in p53 stability, transactivation, and involvement in senescence-regulatory pathways, we can gain crucial insights into mechanisms underlying dysregulated tumor suppression and accelerated aging. The gene discussed is TP53; the disease is neoplasm.